	Insulin detemir
Fasting plasma glucose
Oral glucose-lowering agents
Body weight
Insulin supplementation
Glucose control
Type 2 diabetes
Insulin glargine
Glucose variability
Hypoglycaemia
	type 2 diabetes
insulin detemir
insulin glargine
daily
basal insulin analogues
oral agents
treatment
participants
patients
glargine
glycaemic control
weeks
oral glucose-lowering drugs
dose
adverse events
trial
weight gain
targets
study
randomised
analyses
meal-time insulin
hypoglycaemia
insulin treatment
trial conduct
comparable
body weight
Withdrawal criteria
insulins
present study
similar
ten-point PG profiles
lower
events
FPG
add-on
detemir

